Evidence map›Paper›PMID 37049583›Full record

ArticleNutrients2023

Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn's Disease Patients Rational and Feasible? Data from a Feasibility Test.

Hannes Hoelz, Jeannine Heetmeyer, Anastasia Tsakmaklis, Andreas Hiergeist, Kolja Siebert, Federica De Zen, Deborah Häcker, Amira Metwaly, Klaus Neuhaus, André Gessner and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Hannes HoelzDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, 80337 Munich, Germany.ORCID 0000-0002-7208-6195
Jeannine HeetmeyerDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, 80337 Munich, Germany.
Anastasia TsakmaklisClinical Microbiome Research Group, Department of Internal Medicine I, University Hospital of Cologne, 50931 Cologne, Germany.ORCID 0000-0001-5380-3614
Andreas HiergeistInstitute for Microbiology and Hygiene, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0002-3154-0638
Kolja SiebertDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, 80337 Munich, Germany.
Federica De ZenDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, 80337 Munich, Germany.
Deborah HäckerChair of Nutrition and Immunology, Technical University Munich, 85354 Freising-Weihenstephan, Germany.ORCID 0000-0001-7914-9470
Amira MetwalyChair of Nutrition and Immunology, Technical University Munich, 85354 Freising-Weihenstephan, Germany.ORCID 0000-0001-5740-0230
Klaus NeuhausZIEL-Institute for Food and Health, Technical University Munich, 85354 Freising-Weihenstephan, Germany.ORCID 0000-0002-6020-2814
André GessnerInstitute for Microbiology and Hygiene, University Hospital Regensburg, 93053 Regensburg, Germany.
Maria J G T VehreschildClinical Microbiome Research Group, Department of Internal Medicine I, University Hospital of Cologne, 50931 Cologne, Germany.
Dirk HallerChair of Nutrition and Immunology, Technical University Munich, 85354 Freising-Weihenstephan, Germany.
Tobias SchwerdDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, 80337 Munich, Germany.ORCID 0000-0002-2281-4852
Ludwig-Maximilians-Universität München · DELeibniz-Institute for Food Systems Biology at the Technical University of Munich · DETechnical University of Munich · DEUniversity Hospital Regensburg · DEGoethe University Frankfurt · DEUniversity Hospital Cologne · DE

Funding

Deutsche Forschungsgemeinschaft 395357507Leona M. and Harry B. Helmsley Charitable Trust 2847
6 · The paper itself

Abstract

backgroundExclusive enteral nutrition (EEN) is a highly effective therapy for remission induction in pediatric Crohn's disease (CD), but relapse rates after return to a regular diet are high. Autologous fecal microbiota transfer (FMT) using stool collected during EEN-induced clinical remission might represent a novel approach to maintaining the benefits of EEN.

methodsPediatric CD patients provided fecal material at home, which was shipped at 4 °C to an FMT laboratory for FMT capsule generation and extensive pathogen safety screening. The microbial community composition of samples taken before and after shipment and after encapsulation was characterized using 16S rRNA amplicon sequencing.

resultsSeven pediatric patients provided fecal material for nine test runs after at least three weeks of nutritional therapy. FMT capsules were successfully generated in 6/8 deliveries, but stool weight and consistency varied widely. Transport and processing of fecal material into FMT capsules did not fundamentally change microbial composition, but microbial richness was <30 genera in 3/9 samples. Stool safety screening was positive for potential pathogens or drug resistance genes in 8/9 test runs.

conclusionsA high pathogen burden, low-diversity microbiota, and practical deficiencies of EEN-conditioned fecal material might render autologous capsule-FMT an unsuitable approach as maintenance therapy for pediatric CD patients.

Indexed as

Enteral NutritionFecal Microbiota TransplantationChildCrohn DiseaseFeasibility StudiesHumansRemission InductionRNA, Ribosomal, 16SRNA, Ribosomal, 16Sautologous FMTCrohn’s diseaseexclusive enteral nutritionfecal microbiota transferpediatric IBD

Identifiers

PMID37049583
PMCPMC10096730
OpenAlexW4362586127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.